The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome

被引：219

作者：

Wang M. ^{[1
]}

机构：

[1] Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, CA

来源：

Nutrition & Metabolism | / 2卷 / 1期

关键词：

Insulin Resistance; Cortisol; Metabolic Syndrome; Corticosterone; Carbenoxolone;

D O I：

10.1186/1743-7075-2-3

中图分类号：

学科分类号：

摘要：

Glucocorticoids are stress hormones that modulate a large number of physiological actions involved in metabolic, inflammatory, cardiovascular and behavioral processes. The molecular mechanisms and the physiological effects of glucocorticoids have been extensively studied. However, the involvement of glucocorticoid action in the etiology of the Metabolic Syndrome has not been well appreciated. Recently, accumulating clinical evidence and animal genetics studies have attracted growing interest in the role of glucocorticoid action in obesity and insulin resistance. This review will discuss the metabolic effects in the context of glucocorticoid metabolism and establish the association of glucocorticoid action with the features of the Metabolic Syndrome, especially obesity and insulin resistance. Special discussions will be focused on corticosteroid-binding globulin and 11β-hydroxysteroid dehydrogenase type 1, two proteins that mediate glucocorticoid action and have been implicated in the Metabolic Syndrome. Due to the complexities of the glucocorticoid biology and the Metabolic Syndrome and limited space, this review is only intended to provide a general link between the two areas with broad rather than in-depth discussions of clinical, pharmacological and genetic findings. © 2005 Wang; licensee BioMed Central Ltd.

引用

共 148 条

[71] Filipovsky J., Ducimetiere P., Eschwege E., Richard J.L., Rosselin G., Claude J.R., The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men, J Hypertens, 14, 2, pp. 229-235, (1996)
[72] Strain G.W., Zumoff B., Kream J., Strain J.J., Levin J., Fukushima D., Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol, Metabolism, 31, 3, pp. 209-212, (1982)
[73] Moyer A.E., Rodin J., Grilo C.M., Cummings N., Larson L.M., Rebuffe-Scrive M., Stress-induced Cortisol response and fat distribution in women, Obes Res, 2, pp. 255-262, (1994)
[74] Epel E.E., Moyer A.E., Martin C.D., Macary S., Cummings N., Rodin J., Rebuffe-Scrive M., Stress-induced cortisol, mood, and fat distribution in men, Obes Res, 7, 1, pp. 9-15, (1999)
[75] Ljung T., Andersson B., Bengtsson B.A., Bjorntorp P., Marin P., Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: A dose-response study, Obes Res, 4, 3, pp. 277-282, (1996)
[76] Marin P., Darin N., Amemiya T., Andersson B., Jern S., Bjorntorp P., Cortisol secretion in relation to body fat distribution in obese premenopausal women, Metabolism, 41, 8, pp. 882-886, (1992)
[77] Pasquali R., Cantobelli S., Casimirri F., Capelli M., Bortoluzzi L., Flamia R., Labate A.M., Barbara L., The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution, J Clin Endocrinol Metab, 77, 2, pp. 341-346, (1993)
[78] Dimitriou T., Maser-Gluth C., Remer T., Adrenocortical activity in healthy children is associated with fat mass, Am J Clin Nutr, 77, 3, pp. 731-736, (2003)
[79] Reinehr T., Andler W., Cortisol and its relation to insulin resistance before and after weight loss in obese children, Horm Res, 62, 3, pp. 107-112, (2004)
[80] Fraser R., Ingram M.C., Anderson N.H., Morrison C., Davies E., Connell J.M., Cortisol effects on body mass, blood pressure, and cholesterol in the general population, Hypertension, 33, 6, pp. 1364-1368, (1999)

← 3 4 5 6 7 8 9 10 11 12 →